Expertise in
36
conditions

Dr. Asad D. Fraser

Rheumatology
Graves Gilbert Clinic PLLC
2724 Nashville Rd, 
Bowling Green, KY 
Expertise in
36
conditions
Graves Gilbert Clinic PLLC
2724 Nashville Rd, 
Bowling Green, KY 

Overview

Asad Fraser is a Rheumatologist practicing medicine in Bowling Green, Kentucky.

Dr. Fraser is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Undifferentiated Connective Tissue Disease (UCTD), Psoriasis, Rheumatoid Arthritis (RA), and Psoriatic Arthritis.

He is actively involved in clinical research, participating in 6 clinical trials.

Specialties

Rheumatology

Licenses

Internal Medicine in KY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Graves Gilbert Clinic PLLC
2724 Nashville Rd, Bowling Green, KY 42101
Other Locations
Gilbert Barbee Moore & McIlvoy PSC
201 Park St, Bowling Green, KY 42101

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
Enrollment Status: Terminated
Publish Date: February 07, 2024
Intervention Type: Drug, Biological
Study Drugs: Otilimab, csDMARD
Study Phase: Phase 3
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
26
conditions
Expertise in
26
conditions
Referral may be required

Graves Gilbert Clinic PLLC

2724 Nashville Rd, 
Bowling Green, KY 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances

Neha Pansuria is a Rheumatologist practicing medicine in Bowling Green, Kentucky. Dr. Pansuria is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Psoriasis, Psoriatic Arthritis, and Undifferentiated Connective Tissue Disease (UCTD).

Expertise in
10
conditions
Expertise in
10
conditions
Referral may be required
Before you request

Vanderbilt Lung Institute

719 Thompson Lane, Suite 20300, 
Nashville, TN 
 (60.7 miles away)
615-322-2386
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Leslie Crofford is a Rheumatologist practicing medicine in Nashville, Tennessee. Dr. Crofford is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Fibromyalgia, Myositis, Scleroderma, and Systemic Sclerosis (SSc). Dr. Crofford is currently accepting new patients.

Expertise in
42
conditions
Dr. Victor M. Byrd
Rheumatology
Expertise in
42
conditions
Dr. Victor M. Byrd
Rheumatology
Referral may be required
Before you request

Heritage Medical Associates: 222 Medical Office Building

222 22nd Ave N, 
Nashville, TN 
 (58.5 miles away)
629-255-2183
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Victor Byrd is a Rheumatologist practicing medicine in Nashville, Tennessee. Dr. Byrd is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Psoriatic Arthritis, Sjogren Syndrome, Psoriasis, and Rheumatoid Arthritis (RA). Dr. Byrd is board certified in The American Board Of Internal Medicine - Rheumatology and The American Board Of Internal Medicine - Internal Medicine. Dr. Byrd is currently accepting new patients.

Frequently Asked Questions about Dr. Asad D. Fraser

How do I make an appointment with Dr. Asad D. Fraser?

You can book an appointment with Dr. Asad D. Fraser by calling their office at 270-783-3338. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Asad D. Fraser a top-rated expert for Undifferentiated Connective Tissue Disease (UCTD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Asad D. Fraser is classified as an Distinguished expert for Undifferentiated Connective Tissue Disease (UCTD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Asad D. Fraser specialize in?

While Dr. Asad D. Fraser is a Rheumatology, they have specific expertise in Undifferentiated Connective Tissue Disease (UCTD), Psoriasis, and Rheumatoid Arthritis (RA). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Asad D. Fraser accept my insurance?

Dr. Asad D. Fraser accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 270-783-3338 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fraser's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 29 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile